Carregant...
iRECIST: how to do it
BACKGROUND: iRECIST for the objective monitoring of immunotherapies was published by the official RECIST working group in 2017. MAIN BODY: Immune-checkpoint inhibitors represent one of the most important therapy advancements in modern oncology. They are currently used for treatment of multiple malig...
Guardat en:
| Publicat a: | Cancer Imaging |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942293/ https://ncbi.nlm.nih.gov/pubmed/31900236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0281-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|